TrialJAMA oncology2018

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.

Clara Montagut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.